LeafNLP Demos
Back to explore

Report #2873726

Received Nov 20, 2025

Reports are unverified and do not show that a vaccine caused an event. Full disclaimer

Overview

Sex
Male
Age
50 yrs
State
GA
Recovered
Unknown
Vaccinated
Jul 24, 2025
Onset
Jul 24, 2025
Days to onset
0
Hospital days
—

Vaccines (1)

TypeNameManufacturerDoseLotRoute / Site
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS2PJ353—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

received the first dose of Shingrix on June 25, 2025 and then received the second dose on July 24, 2025; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of drug dose administration interval too short in a 50-year-old male patient who received Herpes zoster (Shingrix) (batch number PJ353) for prophylaxis. Concomitant products included Varicella zoster vaccine rgE (CHO) (Shingrix). On 24-JUL-2025, the patient received the 2nd dose of Shingrix. On 24-JUL-2025, an unknown time after receiving Shingrix, the patient experienced drug dose administration interval too short (Verbatim: received the first dose of Shingrix on June 25, 2025 and then received the second dose on July 24, 2025). The outcome of the drug dose administration interval too short was not applicable.

Other medications

SHINGRIX